- TheStreet.com•5 days ago
The technical signs indicate the stage may be set for new highs in the maker of medical devices.
- The Wall Street Journal•7 days ago
Medtronic is facing new competition in supplying devices for deep brain stimulation, an established therapy for moderating the symptoms of Parkinson’s disease.
- Investor's Business Daily•13 days ago
As Medtronic preps to dredge Edwards' share of the heart valve-replacement market, others are lining up to gouge Medtronic's business.
BSX : Summary for Boston Scientific Corporation C - Yahoo Finance
Boston Scientific Corporation (BSX)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||23.45 - 23.91|
|52 Week Range||15.67 - 24.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||449.43|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|